share_log

HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $3 Price Target

Moomoo 24/7 ·  Mar 22 14:54

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment